RxDoctor Payments Data

Leah Hinkle, MD

Family Medicine · Forest, VANPI 1740264803

Payments from drug & device makers

$8,808in general payments, 2019–2025

Across 608 payments — averaging $14.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • Pfizer$934
  • Lilly USA, LLC$786
  • Johnson & Johnson$599
  • AbbVie$542
  • Amgen$493
  • plus $4K from 41 others

What the payments were for

  • Food & beverage$8,801100%
  • Education$70%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,808 in reported general payments places this provider in the 90th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$260,700
Medicare patients
402
Services billed
9,522

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide55$69,247
FarxigaDapagliflozin Propanediol89$68,637
EliquisApixaban50$58,335
JanuviaSitagliptin Phosphate24$28,342
XareltoRivaroxaban18$28,077
JardianceEmpagliflozin14$23,784
Breo ElliptaFluticasone/Vilanterol36$23,673
Spiriva RespimatTiotropium Bromide27$20,038
MounjaroTirzepatide17$18,690
TrulicityDulaglutide11$18,549
Nucynta ErTapentadol Hcl11$17,299
MyrbetriqMirabegron18$11,814
Humalog Mix 75-25 KwikpenInsulin Lispro Protamin/Lispro13$9,947
Xtampza ErOxycodone Myristate12$5,380
Duloxetine Hcl145$4,966

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,568$69,24755 claims
AstraZenecaFarxiga$305$68,63789 claims
PfizerEliquis$934$58,33550 claims
Boehringer IngelheimJardiance, Spiriva Respimat$449$43,82341 claims
Lilly USA, LLCMounjaro, Trulicity$786$37,23928 claims
MerckJanuvia$163$28,34224 claims
Johnson & JohnsonXarelto$599$28,07718 claims
GSKBreo Ellipta$354$23,67336 claims
Astellas Pharma US IncMyrbetriq$180$11,81418 claims
AbbVieSynthroid$542$1,86634 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,553 family medicine providers in Virginia.

Other family medicine in Forest

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →